Creative BioMolecules Inc. (CBMI), Enzon Inc. (ENZN) deal

The companies finalized their agreement to cross-license ENZN's Single-Chain Antigen-Binding (SCA) protein technology and CBMI's Biosynthetic

Read the full 161 word article

How to gain access

Continue reading with a
two-week free trial.